According to a new report published by UnivDatos Markets Insights, the Urinalysis Market was valued at more than USD 3.5 billion in 2020 and is expected to grow at a CAGR of around 5.5% from 2022-2028. The analysis has been segmented into Product (Consumables (Pregnancy & Fertility Kits; Dipsticks; Disposables; and Reagents), Instruments (Point of Care Urine Analyzers; Automated Biochemical Analyzers; and Semi-Automated Biochemical Analyzers); Application (Disease Screening (UTIs; Diabetes; Kidney Disease; Hypertension; Liver Disease; and Others); Pregnancy & Fertility Testing); End-User (Hospitals; Clinical Laboratories; Home Care; Research & Academics; and Others)

Access sample report (including graphs, charts, and figures):- https://univdatos.com/get-a-free-sample-form-php/?product_id=31741

The urinalysis market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the urinalysis market. The urinalysis market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the urinalysis market at the global and regional levels.

Click here to view the Report Description & TOC - https://univdatos.com/report/urinalysis-market/

 

Market Overview

Urinalysis is a laboratory test that enables the diagnosis of several kidney and urinary tract-related diseases and aid in the management of diabetes. It deals with the identification of the content, color, and concentration of urine. These tests have gained considerable momentum in today’s generation due to the higher adoption of a sedentary lifestyle. Moreover, companies in the market are rapidly launching new products which are also boosting the market’s growth during the forecast period. For instance, in February 2021, 77 Elektronika Kft. announced the launch of LabStrip U mALB/CREA urine test strips. The product is intended for the rapid and semi-quantitative recognition of creatinine and albumin compounds in native urine. Such advancements are expected to strengthen the company’s product offerings in the emerging markets.

Factors such as a surge in the prevalence of chronic diseases globally and rising rates of obesity are the key drivers boosting the growth of the market. Apart from this, an increase in disposable income and the high adoption of a sedentary lifestyle is also having a positive impact on the market during the forecast period.

Some of the major players operating in the market include Siemens Healthcare GmbH; F. Hoffmann-La Roche Ltd.; Bio-Rad Laboratories, Inc.; Abbott; Siemens Healthineers; ACON Laboratories, Inc.; Sysmex Corporation; Cardinal Health Inc.; Thermo Fisher Scientific; and Danaher Corporation

Access sample report (including graphs, charts, and figures):- https://univdatos.com/get-a-free-sample-form-php/?product_id=31741

COVID-19 Impact

The recent covid-19 pandemic has disrupted the world and has brought a state of shock to the global economy. The global pandemic has impacted the healthcare industry and has transformed the way healthcare is delivered. The urinalysis market was positively affected as kidney disorders were highly prevalent among COVID-19 individuals. According to an article published in Nature Reviews Nephrology in October 2020, the urinalysis study using dipsticks reported among the 32% of patients hospitalized with COVID-19 for whom urinalysis was available, 42.1% had significant proteinuria, with leukocyturia and haematuria in 36.5% and 40.9%, respectively. Also, urinalysis data from 442 hospitalized Chinese patients with COVID-19 resulted proteinuria was present in 43.9%.

The global urinalysis market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.

·       Based on product, the market is categorized into instruments and consumables. The instrument segment is expected to grow with high CAGR rates during the forecast period owing to the launch of new enhanced products in the global market. For instance, in September 2022, Olive Diagnostics launched Olive KG, which is the world’s first AI- and spectroscopy-based device, which performs high-quality analysis of important parameters in the patients’ urine in each urination, in a 100% passive way and without any need for additional accessories. 

·       On the basis of application, the market is categorized into disease screening and pregnancy & fertility testing. The disease screening segment due to the unmet need for the early diagnosis of the diseases, rise in prevalence of chronic diseases such as diabetes, and obesity, the rising aging population, and growing awareness for conducting regular health check-ups are some of the key factors driving the growth of the market.

·       Based on the end-user, the urinalysis market is segmented into hospitals, clinical laboratories, home care, research & academics, and others. Home care is expected to witness higher CAGR rates during the forecast period due to the rising launch of home-based UTI kits. For instance, in August 2020, the TestCard launched non-invasive at home UTI test kit in the UK. The users can access testing results through the accompanying mobile app and share information with a healthcare professional. This test kit is available at a retail pharmacy at a cost of USD 12.06.

Have a Look at the Chapters - https://univdatos.com/report/urinalysis-market/

 

Urinalysis Market Geographical Segmentation Includes:

·       North America (United States, Canada, and Rest of North America)

·       Europe (Germany, United Kingdom, Spain, Italy, France, and the Rest of Europe)

·       Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific)

·       Rest of the World

In 2020, North America held a significant share of the global urinalysis market which is due to the increasing prevalence of chronic diseases associated with the rising awareness regarding the early diagnosis of the disease. For instance, according to the Centers for Disease Control and Prevention (CDC) in 2020, more than 15% of adults in the U.S. were estimated to have CKD. Apart from this, as per the data from National Diabetes Statistics, in 2020, around 34.2 million of the U.S. population had diabetes. Thus, the increase in the prevalence of such diseases that require frequent urine sample analysis will drive the growth of the market during the forecast period.

The major players targeting the market include

·       Siemens Healthcare GmbH  

·       F. Hoffmann-La Roche Ltd.  

·       Bio-Rad Laboratories, Inc.    

·       Abbott         

·       Siemens Healthineers            

·       ACON Laboratories, Inc.       

·       Sysmex Corporation

·       Cardinal Health Inc.

·       Thermo Fisher Scientific       

·       Danaher Corporation                          

 

Competitive Landscape

The degree of competition among prominent global companies has been elaborated by analyzing several leading key players operating worldwide. The specialist team of research analysts sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative product launches, partnerships, mergers, or acquisitions by leading companies in the Urinalysis market. The major players have been analyzed by using research methodologies for getting insight views on global competition.

Key questions resolved through this analytical market research report include:

• What are the latest trends, new patterns, and technological advancements in the urinalysis market?

• Which factors are influencing the urinalysis market over the forecast period?

• What are the global challenges, threats, and risks in the urinalysis market?

• Which factors are propelling and restraining the urinalysis market?

• What are the demanding global regions of the urinalysis market?

• What will be the global market size in the upcoming years?

• What are the crucial market acquisition strategies and policies applied by global companies?

We understand the requirement of different businesses, regions, and countries, we offer customized reports as per your requirements of business nature and geography. Please let us know If you have any custom needs.